Solostar pen

If you’re an Apidra user, listen up!
Sanofi Aventis has announced that due to a technical malfunction at their plant in Frankfurt, Germany, production on all Apidra SoloSTAR insulin pens has come to a screeching halt. Sanofi has made it clear that this is an issue with the manufacturing of the pens themselves, not the insulin. Apidra insulin itself is running strong, and patients won’t have issues with previously manufactured insulin pens or any vials…